🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Teva Pharmaceutical Industries Limited

TEVA Healthcare
$34.63 +$0.07 (0.20%)
Market Cap: $40.32 B
Gurus Holding
11
Popularity Rank
#381
% of Shares Held
1.29%
Net Activity (Q1 2026)
-$370.45 M

Guru Ownership Trend

Guru Analysis for Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Industries Limited (TEVA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 11 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $519.2 M.

Top institutional holders include Larry Robbins and David Einhorn.

Notably, Larry Robbins has expressed high conviction in this stock, allocating 5.04% of their equity portfolio to it.

Institutional sentiment is currently Bearish. This is evidenced by a $370.45 M net outflow during the quarter.

Recent activity highlights Jefferies Group who increased their stake by 113.5%. Conversely, Larry Robbins reduced exposure by 60.2%.

Key Holders

Top 5 by Value

$200.61 M
$87.67 M
$34.05 M
$33.99 M

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$47.36 M
Total Buy Value
New Buys 1
Additions 4
-$417.81 M
Total Sell Value
Reductions 6
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
7
Net Buyers
5

FAQs for Teva Pharmaceutical Industries Limited (TEVA)

Major holders include Larry Robbins ($200.61 M), David Einhorn ($87.67 M), Stanley Druckenmiller ($71.6 M). According to the latest reported data, 11 tracked investment managers collectively hold approximately 14.99 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $370.45 M, with 5 managers increasing positions and 7 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 1 fully exited TEVA. The total reported sell value was $417.81 M.

Yes, 1 managers opened new positions in TEVA, and 4 increased their existing holdings. The total reported buy value was $47.36 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
5.04% Reduce -60.2% 6,660,220 $200.61 M Q1 2026
2.75% Reduce -4.8% 2,910,729 $87.67 M Q1 2026
2.12% Reduce -59.5% 2,377,285 $71.6 M Q1 2026
0.04% New Buy 1,130,507 $34.05 M Q1 2026
0.15% Add 49.6% 1,128,406 $33.99 M Q1 2026
0.03% Add 8.9% 544,501 $16.4 M Q1 2026
0.00% Add 9.1% 75,218 $2.27 M Q1 2026
0.02% Reduce -35.1% 68,279 $2.06 M Q1 2026
0.02% Reduce -24.2% 66,100 $1.99 M Q1 2026
0.01% Add 113.5% 31,564 $950,708 Q1 2026
0.00% Reduce -2.3% 43 $1,219 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form